• Phare
  • Validé par KD/KO

Anticorps Recombinant de lapin anti-AKT1-Specific

AKT1-Specific Recombinant Antibody for WB, IHC, FC (Intra), IP, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain, rat, souris

Applications

WB, IHC, FC (Intra), IP, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

5O9

N° de cat : 80816-1-PBS

Synonymes

AKT, AKT 1, AKT1, 5O9, EC:2.7.11.1



Informations sur le produit

80816-1-PBS cible AKT1-Specific dans les applications de WB, IHC, FC (Intra), IP, Indirect ELISA et montre une réactivité avec des échantillons Humain, rat, souris

Réactivité Humain, rat, souris
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène AKT1-Specific Protéine recombinante Ag0213
Nom complet v-akt murine thymoma viral oncogene homolog 1
Masse moléculaire calculée 56 kDa
Poids moléculaire observé 56-62 kDa
Numéro d’acquisition GenBankBC000479
Symbole du gène AKT1
Identification du gène (NCBI) 207
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

The serine-threonine protein kinase AKT1 is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3-kinase. In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery. 80816-1-RR recognizes AKT1 specifically.

{{ptg:RelatedPrimaryAntibodies}}